Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2000, p. 3473-3475, Vol. 44, No. 12
Institute of Infectious Diseases and Public
Health, University of Ancona, Ancona, Italy
Received 2 May 2000/Returned for modification 27 June 2000/Accepted 25 September 2000
A cell culture system and double fluorogenic staining were used to
study the susceptibility of Cryptosporidium parvum to
membrane-active antibiotics. Buforin II and magainin II exerted a
cytotoxic effect on sporozoites but did not consistently affect oocyst
viability. Lasalocid and nigericin demonstrated less activity against
sporozoites but reduced the infectivity of oocysts.
Several compounds have been proposed
as anticryptosporidial agents (3, 4, 9, 14). The
membrane-active polyether ionophores are lipid-soluble molecules that
transport polar cations across the cell membranes. Lasalocid, a
polyether carboxylic acid ionophore, was isolated from
Streptomyces lasaliensis. It disrupts membrane potential and
stimulates ATPase activity in mitochondria (5, 10, 11).
Nigericin, isolated from Streptomyces hygroscopicus, is
another polyether ionophore which exerts similar activity
(5). Today only lasalocid is therapeutically useful: it is
an effective anticoccidial drug for poultry and farm animals. The
vertebrate polycationic peptides demonstrate a broad spectrum of
antimicrobial activity. Their mechanisms of action are under
investigation: perturbation of the membrane function, formation of
transient channels, and attachment to cytosolic targets are those
recently proposed (6, 7, 13). In the present study,
short-term exposures to membrane effectors were performed to
investigate the anticryptosporidial activity of these compounds.
Pooled Cryptosporidium parvum oocysts were suspended in
Dulbecco's modified Eagle's medium (BioWhittaker Inc., Walkersville, Md.) and enumerated in a hemocytometer chamber. Oocyst viability was
estimated by using an excystation procedure and vital dye staining
(3).
Excystation of sporozoites was achieved by incubating oocysts in
phosphate-buffered saline (PBS) (pH 7.2) containing 0.25% trypsin and
0.75% sodium taurocholate for 60 min at 37°C. Free sporozoites were
isolated from excysted oocysts by passage through a polycarbonate
filter (2.0-µm pore size) and were counted in a hemocytometer.
Sporozoite viability was confirmed by double staining with fluorescein
diacetate and propidium iodide (2, 3, 12).
Oocysts and sporozoites were separately resuspended in 0.1 ml of PBS.
Following the addition of 0.1 ml of 40-µg/ml fluorescein diacetate
and 0.15 ml of 20-µg/ml propidium iodide and incubation at room
temperature for 5 min, the incubation mixtures were further diluted 1:1
with PBS and analyzed by flow cytometry (1).
All drugs were provided by Sigma-Aldrich (Milan, Italy). Buforin II and
magainin II were examined at concentrations of 10 and 100 µg/ml.
Lasalocid and nigericin were examined at concentrations of 0.1 and 1 µg/ml. Oocysts (5 × 103 organisms/ml) and
sporozoite suspensions (2 × 104 organisms/ml) were
exposed to each compound for 0, 5, 10, 15, 20, 30, 40, 50, 60, 120, and
180 min at 37°C. Duplicate samples (0.1 ml) were withdrawn and
separated in two half-series: the first series was examined by flow
cytometry after double staining; the second was serially diluted in 10 mmol of 20 mM HEPES buffer (pH 7.2) to minimize the carryover effect
and was plated onto a cell monolayer. Experiments were performed in triplicate.
A-549 cells (BioWhittaker) were maintained in Dulbecco's modified
Eagle's medium with 10% fetal calf serum (BioWhittaker), 1%
L-glutamine (BioWhittaker), 20 mM HEPES, penicillin G (100 U/ml), streptomycin (100 µg/ml), and amphotericin B (0.5 µg/ml). Viability was assessed by trypan blue exclusion. The infection of the
cell monolayer was initiated by adding 0.1 ml of drug-exposed organism
suspensions. Infected cell cultures were kept at 37°C in 5%
CO2 throughout the study. Parasite growth was assessed at 48 h postinfection in 100 random fields. The results from flow cytometry were reported as percentages of viable organisms, while from
the cell culture they were evaluated by comparing parasite counts from
plates infected with drug-exposed organisms with counts from control
plates infected with nonexposed organisms. Each value was reported as
the geometric mean of three experiments.
Flow cytometry demonstrated differences in the percentages of the
viable populations (Tables 1 and
2). In the sporozoite series, the
percentage of the viable population rapidly fell under 10% after 20- and 60-min exposures to the peptides at concentrations of 100 and 10 µg/ml, respectively. In contrast, the viable sporozoite population
remained above 70 and 50% after 180 min of exposure to the ionophores
at concentrations of 0.1 and 1 µg/ml, respectively. In the oocyst
series, the percentage of the viable organisms remained above 65%
after 180 min of exposure to the highest peptide concentrations, while
it fell under 50% after 180 min of exposure to the ionophores at a
concentration of 1 µg/ml.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Short-Term Exposure to Membrane-Active Antibiotics
Inhibits Cryptosporidium parvum Infection in Cell
Culture
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Flow cytometry: effects of buforin II, magainin II,
lasalocid, and nigericin on sporozoite viability
TABLE 2.
Flow cytometry: effects of buforin II, magainin II,
lasalocid, and nigericin on oocyst viability
The average number of parasites in plates infected with nonexposed sporozoites was 76.9 (range, 63.3 to 87.6), while in plates infected with nonexposed oocysts it was 43.3 (range, 31.9 to 53.6). In the sporozoite series, complete inhibition of parasite growth was observed after 20 and 60 min of exposure to the peptides at concentrations of 100 and 10 µg/ml, respectively, and after 120 min of exposure to the ionophores at a concentration of 1 µg/ml. In the oocyst series, no compound produced complete inhibition of parasite growth. Buforin II and magainin II were similarly active, effecting respective reductions of 18.8 and 15.1% after 180 min of exposure at 100 µg/ml. The ionophores showed the highest activity against oocysts: after 180 min of exposure, they suppressed the growth of meronts and gamonts by more than 20 and 30% at concentrations of 0.1 and 1 µg/ml, respectively.
Most studies of the mode of action of cationic peptides have concerned their activity against gram-negative bacteria (6, 7). One could speculate that the excysted sporozoites are susceptible because their cytoplasmic membrane is somewhat structurally similar to the bacterial cytoplasmic membrane. However, inside oocysts they are surrounded by an additive single-unit membrane and by the thick, two-layered, environmentally resistant oocyst wall, which may explain the slight activity exerted by the peptides against nonexcysted organisms. In addition, the peptides could have caused functional changes in apical complex or surface molecules involved in attachment, invasion, and intracellular development: they could have determined alteration of the apical complex glycoprotein that contains a sporozoite ligand for epithelial cells (8). Nevertheless, flow cytometry confirmed that buforin II and magainin II were lethal for sporozoites. On the other hand, lasalocid and nigericin exerted the highest activity against oocysts.
Developing an in vitro drug screening system is an important step toward the initial identification of candidate anticryptosporidial compounds. In this study we used two different laboratory methods, a cell culture system and double fluorogenic staining, to evaluate the anticryptosporidial activity of short-term exposure to ionophores and cationic peptides. Further investigations are needed before firm conclusions about reliability can be drawn.
| |
ACKNOWLEDGMENTS |
|---|
This study was in part supported by a grant from M.U.R.S.T. 1999-2000, Rome, Italy.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Clinica Malattie Infettive, c/o Azienda Ospedaliera Umberto I, Piazza Cappelli, 1, I-60121 Ancona, Italy. Phone: 39-071-596-3467. Fax: 39-071-596-3468. E-mail: cmalinf{at}popcsi.unian.it.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adams, R. B., R. L. Guerrant, S. Zu, G. Fang, and J. K. Roche. 1994. Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model. J. Infect. Dis. 169:170-177[Medline]. |
| 2. | Arrowood, M. J., J. R. Mead, L. Xie, and X. You. 1996. In vitro anticryptosporidial activity of dinitroaniline herbicides. FEMS Microbiol. Lett. 136:245-249[Medline]. |
| 3. |
Giacometti, A.,
O. Cirioni,
F. Barchiesi, and G. Scalise.
2000.
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines.
J. Antimicrob. Chemother.
45:375-377 |
| 4. | Griffiths, J. K. 1998. Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis. Adv. Parasitol. 40:30-85. |
| 5. | Gumila, C., M. L. Ancelin, A. M. Delort, G. Jeminet, and H. J. Vial. 1997. Characterization of the potent in vitro and in vivo antimalarial activities of ionophore compounds. Antimicrob. Agents Chemother. 41:523-529[Abstract]. |
| 6. | Hancock, R. E. W. 1997. Peptide antibiotics. Lancet 349:418-422[CrossRef][Medline]. |
| 7. |
Hancock, R. E. W., and D. S. Chapple.
1999.
Peptide antibiotics.
Antimicrob. Agents Chemother.
43:1317-1323 |
| 8. |
Langer, R. C., and M. W. Riggs.
1999.
Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells.
Infect. Immun.
67:5282-5291 |
| 9. | O'Donoghue, P. J. 1995. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25:139-195[CrossRef][Medline]. |
| 10. | Oz, H. S., W. T. Hughes, and J. E. Rehg. 1997. Efficacy of lasalocid against murine Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother. 41:191-192[Abstract]. |
| 11. |
Schwingel, W. R.,
D. B. Bates,
S. C. Denham, and D. K. Beede.
1989.
Lasalocid-catalyzed proton conductance in Streptococcus bovis as affected by extracellular potassium.
Appl. Environ. Microbiol.
55:259-260 |
| 12. | Upton, S. J., M. Tilley, M. V. Nesterenko, and D. B. Brillhart. 1994. A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiol. Lett. 118:45-50[CrossRef][Medline]. |
| 13. |
Wade, D.,
A. Boman,
B. Wåhlin,
C. M. Drain,
D. Andreu,
H. G. Boman, and R. B. Merrifield.
1990.
All-D amino acid-containing channel-forming antibiotic peptides.
Proc. Natl. Acad. Sci. USA
87:4761-4765 |
| 14. | Woods, K. M., M. V. Nesterenko, and S. J. Upton. 1996. Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. Ann. Trop. Med. Parasitol. 90:603-615[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |